Next 10 |
home / stock / jazz / jazz articles
Following President Biden’s brief mention of cannabis reform in the State of the Union speech last month and VP Kamala Harris‘s recen...
If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your...
"Tell me and I forget, teach me and I may remember, involve me and I learn." Benjamin Franklin When it comes to the cannabis industry, one of the ...
An Australian, vertically integrated plant-based medicine company, Cannatrek, will collaborate with a Japanese University to empower research on m...
The negative sentiment observed in the stock market at the beginning of the year appears to persist, with index futures pointing to a lower opening...
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selecti...
Japan’s Parliament passed a bill Wednesday legalizing medical products derived from cannabis. The news comes some three weeks after the ...
Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants cond...
Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a m...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 PR Newswire Overall survival and additional long-term follow-up data from the Phase 2b HERIZON-BTC-01 trial in previously treated HER2-positive metastatic biliary tract cancer ...
Originally published by Jazz Pharmaceuticals NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face when living with the condition. Jazz wants the epilepsy community know that they are not alone and showed support by sporting pu...
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire DUBLIN , April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednes...